Found: 4
Select item for more details and to access through your institution.
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 4, p. 483, doi. 10.1016/j.clgc.2023.04.008
- By:
- Publication type:
- Article
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat.
- Published in:
- Journal of Cancer Education, 2024, v. 39, n. 1, p. 58, doi. 10.1007/s13187-023-02375-9
- By:
- Publication type:
- Article
Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis‐associated acquired factor X deficiency.
- Published in:
- Transfusion, 2023, v. 63, n. 9, p. 1773, doi. 10.1111/trf.17477
- By:
- Publication type:
- Article
Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 7, p. 649, doi. 10.1002/pros.24498
- By:
- Publication type:
- Article